Can reminders and info get more women screened for cancer?
NCT ID NCT07214051
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether providing educational materials and follow-up calls could increase cancer screening rates among women in Puerto Rico who were overdue for breast, cervical, or colorectal cancer screenings. 500 women aged 21-75 took part, with half receiving the intervention. The goal was to see if community-based outreach could overcome barriers like distrust and lack of access.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cancer screening information and reminders
- What this could lead to
- If successful, this approach could increase cancer screening rates and early detection in underserved communities.
- What could go wrong
- This is a completed behavioral study, not a drug trial. Results may not apply to other populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER PREVENTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Puerto Rico, Comprehensive Cancer Center
San Juan, PR, 00926, Puerto Rico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Bollywood dance and fitness trackers: a new weapon against breast cancer?
- Health education boosts Well-Being in cervical cancer patients?
- Lifestyle advice after positive screening may cut colon cancer risk
- Can a broader HPV vaccine boost protection after the original shot?
- Can a free online course cut colon cancer risk? new study aims to find out
- Stool test vs. colonoscopy: new trial aims to prevent colon cancer in High-Risk patients